ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
No Thumbnail Available
Date
2021
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
Description
Keywords
Angiotensin-Converting Enzyme 2 , Asthma , COVID-19 , Humans , SARS-CoV-2 , angiotensin converting enzyme 2 , biological product , ciclesonide , corticosteroid , steroid , transcriptome , allergic asthma , asthma , chronic obstructive lung disease , consensus , coronavirus disease 2019 , geographic distribution , human , inflammation , Letter , multiple chronic conditions , prevalence , priority journal , Severe acute respiratory syndrome coronavirus 2 , asthma , complication , etiology , physiology